The DPS Boston office offers specialty architectural, engineering and construction services to bioscience, microelectronics and specialty chemicals clients. Our highly specialized teams design and build facilities that turn our clients’ innovations into life-saving, life-enhancing products. More than 85% of our business comes from existing clients; testament to the trust and confidence DPS earns from the companies and people we work with.
DPS often partners with our Boston-based architectural affiliate TRIA Design—a principal-led firm offering specialized architecture and design services to scientific and technology organizations.
Simon is an experienced business leader with over 25 years experience in Engineering design and consultancy working predominantly in the Water, Energy and infrastructure sectors for large ‘blue chip’ and government clients.
Simon brings global insight, a collaborative style and influence, enjoys working with people to enhance collaboration and create engagement whilst delivering the highest quality service in demanding, highly regulated and changing business environments.
Simon joined Arcadis in 2014 taking on the role of leading the Water, Power and Utilities sector, and took additional responsibility for the Environment, Safety and Industry business in early 2018.
In October 2021 Simon was appointed as Country Director for the UK & Ireland, and following many years leading the Resilience business in the UK was appointed as President of Arcadis DPS Group at the end of 2022.
In his role as Senior Vice President, Boston Project Operations Paul leads the strategic direction and continued growth of the Boston office, with a focus on expanding its client base and driving project operations improvements. He is responsible for sales and marketing of DPS Boston’s services including architectural and engineering design; commissioning, qualification and validation (CQV); and construction management.
Paul brings more than 30 years of experience in the design, engineering management, and construction management of pharmaceutical and biotechnology capital projects, and his expertise spans both project leadership and business leadership roles.
Paul offers proven leadership skills in the overall responsibility and execution of complex life sciences projects in areas that include client liaison; project execution plans and scheduling; estimating and budgets; directing execution of engineering, design, procurement, construction, and start-up; and commercial and financial stewardship of projects.
Jim brings more than 30 years of experience in the AEC industry to his position of SVP, U.S. Business Development. He joined DPS Group in 2015 and previously served as Vice President of Strategic Development for Boston’s Project Operations. In this role, he successfully led teams and delivered strategic capital projects for leading biotech/pharmaceutical and advanced technology clients. Jim supports all of DPS’ internal and external client relationships with expert guidance in the areas of planning, risk assessment, site selection, estimating, CQV, and operational readiness. He also has special expertise in strategic planning, real estate development, and risk assessments associated with capital projects and product development in the regulated industry and advanced technology sectors. Additionally, Jim fulfills the role of project sponsor for many of DPS’ strategic project initiatives, providing senior management oversight and guidance to project teams on behalf of clients including Moderna, Sanofi, AbbVie, Acorda, Brammer Bio, and Waters Corporation.
Jim is an active member of ISPE Boston, having previously served as president of the chapter’s board of directors and helping to start the ISPE Boston Chapter Scholarship Fund. He is also a founding member of the I2SL New England Chapter.
Carl Bradbury leads the Construction Management division for the DPS Boston, MA USA office. He brings over 20 years of experience in project construction management, scheduling, budget management, quality standards, safety management, contract reviews, pre-construction, and development of scopes of work. He is highly skilled in coordination of all direct trade labor, material procurement, subcontractor administration, safety, and client relations. Carl’s experience is primarily focused on pharmaceutical and biotechnology projects; and has worked on significant semiconductor, chemical, industrial, and food industry projects. He also holds a Massachusetts Construction Supervisor Licence (CSL).
Chris has over 30 years of experience managing projects for clients in the medical, commercial, advanced tech, and life sciences markets, including those with stringent ISO Cleanroom Classes 4 – 8) and cGMP/cGLP requirements. As Director of Project Management, Chris is responsible for all operations and projects while managing the DPS Boston office’s expanding team of project management professionals. He ensures projects are executed according to industry best practices and in compliance with company and client procedures and guidelines. Chris received a Healthcare Construction Certificate from the American Society for Healthcare Engineering (ASHE), and he is a Construction Safety Technician Instructor with the National Center for Construction Education and Research (NCCER).
In his role as Director of Commissioning, Qualification, and Validation (CQV), Tom leads the DPS Boston Projects CQV group. In this role, Tom will be responsible for project delivery, training, and development of personnel as well as the management of the business unit. Tom was also recently elected to the position of Vice President on the ISPE Boston Board of Directors. An active member since 2011, Tom has served with the Product Show Planning Committee, working in many capacities focusing on education and event exhibitors, culminating in chairing the committee for two years before joining the ISPE Boston Board of Directors in July 2018.
He was elected Secretary in July 2019. A former Submarine Officer in the U.S. Navy, Tom has over 17years of experience managing projects and teams, with nine of those in the pharmaceutical and biotech industry. He is a graduate of Cornell University and earned a master’s degree in Engineering Management from Old Dominion University.